167 related articles for article (PubMed ID: 38764433)
21. Creating a kidney organoid-vasculature interaction model using a novel organ-on-chip system.
Bas-Cristóbal Menéndez A; Du Z; van den Bosch TPP; Othman A; Gaio N; Silvestri C; Quirós W; Lin H; Korevaar S; Merino A; Mulder J; Hoogduijn MJ
Sci Rep; 2022 Nov; 12(1):20699. PubMed ID: 36450835
[TBL] [Abstract][Full Text] [Related]
22.
Zhang D; Du X; Zhang X; Li K; Kong F; Cheng G; Zhao S
Exp Ther Med; 2020 Aug; 20(2):1307-1314. PubMed ID: 32742364
[TBL] [Abstract][Full Text] [Related]
23. Prediction of Acute Hepatotoxicity With Human Pluripotent Stem Cell-Derived Hepatic Organoids.
Kim H; Kim SK; Oelgeschläger M; Park HJ
Curr Protoc; 2024 Apr; 4(4):e1015. PubMed ID: 38597874
[TBL] [Abstract][Full Text] [Related]
24. Application of organoid technology in the human health risk assessment of microplastics: A review of progresses and challenges.
Cong J; Wu J; Fang Y; Wang J; Kong X; Wang L; Duan Z
Environ Int; 2024 Jun; 188():108744. PubMed ID: 38761429
[TBL] [Abstract][Full Text] [Related]
25. Ethical Challenges in Organoid Use.
Mollaki V
BioTech (Basel); 2021 Jun; 10(3):. PubMed ID: 35822766
[TBL] [Abstract][Full Text] [Related]
26. Identification of Predictive Markers for the Generation of Well-Differentiated Human Induced Pluripotent Stem Cell-Derived Kidney Organoids.
Du Z; Shankar AS; van den Bosch TPP; Korevaar SS; Clahsen-van Groningen M; Hoorn EJ; Gribnau J; Reinders MEJ; Baan CC; Hoogduijn MJ
Stem Cells Dev; 2021 Nov; 30(22):1103-1114. PubMed ID: 34549597
[TBL] [Abstract][Full Text] [Related]
27. Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testing.
Salas-Silva S; Kim Y; Kim TH; Kim M; Seo D; Choi J; Factor VM; Seo HR; Song Y; Choi GS; Jung YK; Kim K; Lee KG; Jeong J; Shin JH; Choi D
Biomaterials; 2023 Dec; 303():122360. PubMed ID: 38465578
[TBL] [Abstract][Full Text] [Related]
28. Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation.
Lawlor KT; Vanslambrouck JM; Higgins JW; Chambon A; Bishard K; Arndt D; Er PX; Wilson SB; Howden SE; Tan KS; Li F; Hale LJ; Shepherd B; Pentoney S; Presnell SC; Chen AE; Little MH
Nat Mater; 2021 Feb; 20(2):260-271. PubMed ID: 33230326
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Neurotoxicity With Human Pluripotent Stem Cell-Derived Cerebral Organoids.
Parmentier T; LaMarre J; Lalonde J
Curr Protoc; 2023 Apr; 3(4):e744. PubMed ID: 37068185
[TBL] [Abstract][Full Text] [Related]
30. The Utility of Human Kidney Organoids in Modeling Kidney Disease.
Przepiorski A; Crunk AE; Espiritu EB; Hukriede NA; Davidson AJ
Semin Nephrol; 2020 Mar; 40(2):188-198. PubMed ID: 32303281
[TBL] [Abstract][Full Text] [Related]
31. How to grow a kidney: patient-specific kidney organoids come of age.
Schmidt-Ott KM
Nephrol Dial Transplant; 2017 Jan; 32(1):17-23. PubMed ID: 27411722
[TBL] [Abstract][Full Text] [Related]
32. Guidelines for Manufacturing and Application of Organoids: Liver.
Moon HR; Mun SJ; Kim TH; Kim H; Kang D; Kim S; Shin JH; Choi D; Ahn SJ; Son MJ
Int J Stem Cells; 2024 May; 17(2):120-129. PubMed ID: 38773747
[TBL] [Abstract][Full Text] [Related]
33. Human induced pluripotent stem cell derived kidney organoids as a model system for studying cryopreservation.
Gulieva RE; Higgins AZ
Cryobiology; 2021 Dec; 103():153-156. PubMed ID: 34478696
[TBL] [Abstract][Full Text] [Related]
34. Making a Kidney Organoid Using the Directed Differentiation of Human Pluripotent Stem Cells.
Takasato M; Little MH
Methods Mol Biol; 2017; 1597():195-206. PubMed ID: 28361319
[TBL] [Abstract][Full Text] [Related]
35. High-throughput "read-on-ski" automated imaging and label-free detection system for toxicity screening of compounds using personalised human kidney organoids.
Wang Q; Lu J; Fan K; Xu Y; Xiong Y; Sun Z; Zhai M; Zhang Z; Zhang S; Song Y; Luo J; You M; Guo M; Zhang X
J Zhejiang Univ Sci B; 2022 Jul; 23(7):564-577. PubMed ID: 35794686
[TBL] [Abstract][Full Text] [Related]
36. Kidney organoid research: current status and applications.
Trush O; Takasato M
Curr Opin Genet Dev; 2022 Aug; 75():101944. PubMed ID: 35785592
[TBL] [Abstract][Full Text] [Related]
37. Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy.
Zhang T; Qian C; Song M; Tang Y; Zhou Y; Dong G; Shen Q; Chen W; Wang A; Shen S; Zhao Y; Lu Y
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473926
[TBL] [Abstract][Full Text] [Related]
38. HIF-1α promotes kidney organoid vascularization and applications in disease modeling.
Peng K; Xie W; Wang T; Li Y; de Dieu Habimana J; Amissah OB; Huang J; Chen Y; Ni B; Li Z
Stem Cell Res Ther; 2023 Nov; 14(1):336. PubMed ID: 37981699
[TBL] [Abstract][Full Text] [Related]
39. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
Ho BX; Pek NMQ; Soh BS
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
[TBL] [Abstract][Full Text] [Related]
40. Kidney organoids: Research in developmental biology and emerging applications.
Shimizu T; Yamagata K; Osafune K
Dev Growth Differ; 2021 Feb; 63(2):166-177. PubMed ID: 33569792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
